期刊文献+

一种艰难梭菌毒素基因检测方法的临床应用评价 被引量:7

Evaluation of a real-time PCR assay for the qualitative detection of Ciostridium difficile toxin gene and its clinical application
原文传递
导出
摘要 目的 通过与BD MAX试剂盒检测临床粪便标本中艰难梭菌毒素基因的比对,评价本实验室前期研发的艰难梭菌毒素基因检测方法.方法 本研究为临床应用研究.2014年7月1日至9月30日采集浙江中医药大学附属杭州市第一医院的腹泻患者粪便标本147份,分别采用BD MAX和本实验室前期研发的艰难梭菌毒素基因检测方法进行检测.BD MAX试剂盒采用自动化核酸提取和PCR检测;实验室前期研发方法通过提取粪便DNA后进行荧光定量PCR检测,最后采用SPSS10.0软件进行分析.结果 147份标本中,两方法均检出艰难梭菌毒素B基因阳性33份,阴性114份,其中有4份标本的结果不一致.以BD MAX试剂盒的结果为标准,得出本实验室前期研发的艰难梭菌毒素基因检测方法的敏感度为93.94%(31/33),特异度为98.25%(112/114),阳性预测值为93.94 %(31/33)和阴性预测值为98.25 %(112/114).且上述两种方法检测结果的一致性较好(Kappa值为0.922,P〈0.01).结论 本实验室前期研发的艰难梭菌毒素基因检测方法与BD MAX试剂盒性能相似,敏感度高、特异度强,同时该方法成本低并可直接对腹泻标本进行测定,无需配套提取仪器,更适合我国临床开展常规艰难梭菌毒素基因检测. Objective In comparison of the performances for the detection of Clostridium difficile toxin B genes from stool between BD MAX Cdiff assay and a laboratory-developed (LD) assay.The LD assay was evaluated in clinical application.Methods This study was a clinical application research.A total of 147 stool specimens from patients with diarrhea in Hangzhou First Hospital affiliated with Zhejiang Chinese Medical University were detected by the two assays from 1 July to 30 September 2014.DNA extraction and amplification of the tcdB gene were performed automatically on the BD MAX platform.Meanwhile, the tcdA and tcdB gene were detected by the LD real-time PCR assay after DNA extraction.Then, the results were analyzed by use of SPSS 10.0.Results A total of 147 stool samples were collected.There were 33 C.difficile positive cases and 114 negative cases detected by both of two assays.However, there were four stool samples had incongruent results.In comparison with BD MAX, the LD assay had a sensitivity of 93.94% (31/33), a specificity of 98.25% (112/114), a positive predictive value of 93.94% (31/33), and negative predictive value 98.25% (112/114).Furthermore, the results of the LD assay were statistically coherent with that of the BD assay (Kappa=0.922, P〈0.01).Conclusions The LD assay was highly sensitive and accurate as BD MAX Cdiff assay in the detection of toxigenic Clostridium difficile.Furthermore, this LD assay could be also applied to detection of clinical stool samples directly with low cost.The assay will be more promising in diagnosis of toxigenic C.difficile in clinical application in China due to no additional instrument needed.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2017年第7期511-514,共4页 Chinese Journal of Laboratory Medicine
基金 浙江省医药卫生科技计划项目-重点学科带头人平台(2016DTB005) 国家卫生计生委科学研究基金-浙江省医药卫生重大科技计划(WKJ-ZJ-1507) 浙江省重点研发计划(2015C03048)
关键词 难辨梭菌 细菌毒素类 分子诊断技术 Clostridium difficile Bacterial toxins Molecular diagnostic techniques
  • 相关文献

参考文献1

二级参考文献7

  • 1Bartlett JG. Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism [ J ]. Clin Infect Dis, 1994, 18 Suppl 4 : S265-S272.
  • 2Peterson LR, Mehta MS, Patel PA, et al. Laboratory testing for Clostridium difficile infection : light at the end of the tunnel [J]. Am J Clin Pathol, 2011, 136:372-380.
  • 3Khanna S, Pardi DS. Clostridium difficile infection: new insights into management [ J ]. Mayo Clin Proc, 2012, 87 : 1106-1117.
  • 4Carroll KC. Tests for lhe diagnosis of Clostridium difficile infection : the next generation [J]. Anaerobe, 2011, 17 : 170-174.
  • 5Kubista M. Nucleic acid-based technologies:application amplified [J]. Pharmacogenomics, 2004, 5:767-773.
  • 6Pierce KE, Khan H, Mistry R, et al. Rapid detection of sequenc, e variation in Clostridium difficile genes using LATE-PCR with multiple mismatch-tolerant hybridization probes [ J ]. J Mic.rohiol Methods, 2012, 91:269-275.
  • 7孙长贵,成军.分子诊断技术在临床微生物学检验中的应用[J].中华检验医学杂志,2013,36(2):109-112. 被引量:16

共引文献11

同被引文献41

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部